West Pharmaceutical Services (WST) Goodwill (2009 - 2026)

West Pharmaceutical Services has disclosed Goodwill across 18 years of filings, most recently posting $109.2 million for Q1 2026.

• Goodwill for Q1 2026 came in at $109.2 million, up 1.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $109.2 million (up 1.58% YoY), and the FY2025 annual result was $109.9 million, up 3.68% from the prior year.
• Goodwill came in at $109.2 million for Q1 2026 at West Pharmaceutical Services, down from $109.9 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $110.9 million in Q2 2025 to a low of $104.0 million in Q3 2022.
• The 5-year median for Goodwill is $107.8 million (2023), against an average of $108.0 million.
• Across the five-year window, Goodwill declined 4.5% in 2022 and climbed 3.68% in 2025, its largest moves.
• West Pharmaceutical Services' Goodwill stood at $107.3 million in 2022, then advanced by 1.12% to $108.5 million in 2023, then retreated by 2.3% to $106.0 million in 2024, then increased by 3.68% to $109.9 million in 2025, then slipped by 0.64% to $109.2 million in 2026.
• The last three Goodwill figures came in at $109.2 million (Q1 2026), $109.9 million (Q4 2025), and $110.6 million (Q3 2025), per Business Quant data.